Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 37356Generated: October 26, 2026

4-Methylmorpholine → 6-[(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)carbonyl]-N-(4-pyridinylmethyl)-2-pyridinecarboxamide, hydrochloride

https://huagongshe.com/reaction/37356

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-MethylmorpholineHCID 7972—
Reactant4-PyridinemethanamineHCID 77317—
Reactant2,6-Pyridinedicarbonyl dichlorideHCID 77335—
Reactant8-Chloro-dibenz[b,f]-[1,4]oxazepineHCID 838267—
SolventChloroformHCID 6212—
Product6-[(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)carbonyl]-N-(4-pyridinylmethyl)-2-pyridinecarboxamide, hydrochlorideHCID 131719014—

Reaction Steps

A solution of 8-chloro-dibenz[b,f][1,4]oxazepine (0.77 g), 2,6-pyridine-dicarbonyl chloride (0.68 g) and 4-methylmorpholine (0.367 mL) in CHCl3 (33 mL) was allowed to stand at ambient temperature for 16 hours. To this solution was added 4-(aminomethyl)pyridine (0.34 mL) and the mixture was allowed to stand at ambient temperature for 16 hours. The mixture was concentrated and the residue was extracted with ethyl acetate and saturated NaHCO3. The organic extract was concentrated and the residue chromatographed over silica gel using 50% ethyl acetate in hexane. Appropriate fractions were pooled and concentrated to give the free base of the title compound as a white solid. The HCl salt of the free base was made as described in Example 3.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05420270
Source datasetuspto-grants-1995_05
ORD IDord-f8ddeab8d46441a4b8fa8589c29649fd
Source noteuspto-grants-1995_05